Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: May 2022

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Innovative Medicines Canada/Médicaments novateurs Canada

Pamela Fralick, President (Organization)

Results 1-5 of 5

  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ed Morgan , Director General | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-31
    Posted date: 2022-06-20
    Communication number: 371-536049 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Ajay Rakhra , Chief of Staff | House of Commons

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-05-16
    Posted date: 2022-06-08
    Communication number: 371-533581 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Simon Kennedy - , Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Industry, International Trade, Science and Technology
    Communication date: 2022-05-06
    Posted date: 2022-06-08
    Communication number: 371-533586 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas , Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-05-06
    Posted date: 2022-06-08
    Communication number: 371-533583 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Daniel Saad, A/Director of Policy | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry, Science and Technology
    Communication date: 2022-05-06
    Posted date: 2022-06-08
    Communication number: 371-533580 View associated registration

Return to Monthly Communication Reports by Reporting Period

Date Modified: